HOME > News > Event Recaps > 2024.5.10 Glac Biotech Becomes First Taiwanese Probiotic Manufacturer to Earn U.S. GRAS Certification
2024.5.10 Glac Biotech Becomes First Taiwanese Probiotic Manufacturer to Earn U.S. GRAS Certification
As societies around the world age rapidly, consumers are turning their attention to health knowledge and preventative care. Probiotics have become one of the most popular choices, but a pressing question remains: are
the probiotics we consume truly safe?
The market boom has been dramatic. Since the pandemic, the number of health supplement brands in Taiwan alone has expanded by over 600 companies, reaching 1,540 brands in Q1 2023. Among these, probiotics dominate as a common product offering. Yet because probiotics are live microorganisms, their safety requires an even higher standard of proof.
GRAS Certification: A Global Seal of Trust
In 2023, Glac Biotech — a subsidiary of Synmosa Biopharma and a leader in probiotic manufacturing and OEM services — achieved a milestone that set it apart: official GRAS (Generally Recognized as Safe) certification from the U.S. FDA.
This is the highest safety standard in the global health market, and earning it was no small feat. Since its founding in 2008, Glac has committed to a philosophy of science-based validation, breaking from the old habit of marketing probiotics based only on CFU counts. Instead, Glac has led the market by verifying effective dosages through human clinical studies.
The GRAS recognition not only strengthens Glac’s leadership in Taiwan’s probiotic market but also brings international prestige to the group, showing the world that Taiwan’s probiotics can meet the most stringent safety standards.
World-Class Manufacturing, From Strain to Finished Product
As one of the few Asian manufacturers that fully meets international standards, Glac Biotech backs up its achievements with infrastructure:
A Commitment to Safety Above All
“In the health industry, safety must always come first,” emphasized Chairman Lin Rong-Jin. He reaffirmed Glac Biotech’s mission to continue investing heavily in research, uphold its uncompromising standards, and deliver probiotic solutions that consumers can trust with confidence.
With GRAS certification now under its belt, Glac Biotech has not only achieved a scientific milestone but also given the global probiotics market a reason to look to Taiwan as a trusted source of innovation, safety, and excellence.
the probiotics we consume truly safe?
The market boom has been dramatic. Since the pandemic, the number of health supplement brands in Taiwan alone has expanded by over 600 companies, reaching 1,540 brands in Q1 2023. Among these, probiotics dominate as a common product offering. Yet because probiotics are live microorganisms, their safety requires an even higher standard of proof.
GRAS Certification: A Global Seal of Trust
In 2023, Glac Biotech — a subsidiary of Synmosa Biopharma and a leader in probiotic manufacturing and OEM services — achieved a milestone that set it apart: official GRAS (Generally Recognized as Safe) certification from the U.S. FDA.
This is the highest safety standard in the global health market, and earning it was no small feat. Since its founding in 2008, Glac has committed to a philosophy of science-based validation, breaking from the old habit of marketing probiotics based only on CFU counts. Instead, Glac has led the market by verifying effective dosages through human clinical studies.
The GRAS recognition not only strengthens Glac’s leadership in Taiwan’s probiotic market but also brings international prestige to the group, showing the world that Taiwan’s probiotics can meet the most stringent safety standards.
World-Class Manufacturing, From Strain to Finished Product
As one of the few Asian manufacturers that fully meets international standards, Glac Biotech backs up its achievements with infrastructure:
- A strain library of over 1,000 documented strains.
- Compliance with EU QPS-approved safe strains.
- A track record of science-backed clinical results recognized worldwide.
A Commitment to Safety Above All
“In the health industry, safety must always come first,” emphasized Chairman Lin Rong-Jin. He reaffirmed Glac Biotech’s mission to continue investing heavily in research, uphold its uncompromising standards, and deliver probiotic solutions that consumers can trust with confidence.
With GRAS certification now under its belt, Glac Biotech has not only achieved a scientific milestone but also given the global probiotics market a reason to look to Taiwan as a trusted source of innovation, safety, and excellence.
Media Coverage (Extended Reading)
Business Today — May 10, 2024 (Chinese)
Glac Biotech earns U.S. FDA GRAS certification
-
2023.7.31 Glac Biotech Shines at BioAsia Taiwan — Probiotic Innovations Spark Global Collaboration
-
2024.05.22 Brain Health Innovation Draws Global Attention — Glac Biotech Shines at Vitafoods Europe
-
2023.10.26 Totipro® PE0401 Steals the Spotlight at SSW — Glac Biotech’s Postbiotic Innovation Draws Global Attention
-
2023.2.3 Spring Banquet Celebration — Glac Biotech’s 2023 Performance Soars